Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol PTIX
- Company Protagenic Therapeutics, Inc.
- Price $0.37
- Changes Percentage 4.02
- Change 0.0143
- Day Low $0.33
- Day High $0.38
- Year High $1.87
- Year Low $0.33
- Market Cap $2,679,333
- Price Avg 50 EMA (D) $0.52
- Price Avg 200 EMA (D) $0.78
- Exchange NASDAQ
- Volume 137,447
- Average Volume 368,281
- Open $0.34
- Previous Close $0.36
- EPS -1.27
- PE -0.29
- Earnings Announcement 2025-03-31 10:59:00
- Shares Outstanding $7,241,440
Company brief: PROTAGENIC THERAPEUTICS, INC. (PTIX )
- Healthcare
- Biotechnology
- Dr. Garo H. Armen Ph.D.
- https://www.protagenic.com
- US
- N/A
- 04-27-2021
- US74365N2027
Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound is PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. The company is based in New York, New York.